XDJP:LSE:LSE-Xtrackers Nikkei 225 UCITS ETF 1D (GBX)

ETF | Others |

Last Closing

USD 2016.25

Change

+4.25 (+0.21)%

Market Cap

USD 320.04B

Volume

2.41K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
XMTD:LSE Xtrackers MSCI Taiwan UCITS ET..

N/A

USD 292,109.19B
0R15:LSE SoftBank Group Corp.

N/A

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

N/A

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 592.18B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 592.18B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B

ETFs Containing XDJP:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.05% 48% F 51% F
Dividend Return 0.01% 28% F 20% F
Total Return 5.06% 47% F 51% F
Trailing 12 Months  
Capital Gain 10.89% 50% F 57% F
Dividend Return 0.02% 24% F 19% F
Total Return 10.91% 49% F 57% F
Trailing 5 Years  
Capital Gain 29.50% 49% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.50% 46% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 5.01% 54% F 60% D-
Dividend Return 5.02% 53% F 59% D-
Total Return 0.00% 20% F 13% F
Risk Return Profile  
Volatility (Standard Deviation) 13.33% 55% F 70% C-
Risk Adjusted Return 37.63% 58% F 70% C-
Market Capitalization 320.04B 100% F 99% N/A

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.